Mcl-1 Polyclonal Antibody

MCL1 encodes an anti-apoptotic protein, which is a member of the Bcl-2 family. Alternative splicing results in multiple transcript variants. The longest gene product (isoform 1) enhances cell survival by inhibiting apoptosis while the alternatively spliced shorter gene products (isoform 2 and isoform 3) promote apoptosis and are death-inducing.\

The Mcl-1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Mcl-1 protein expression in various biological samples. This antibody is produced using a polyclonal approach, ensuring a diverse range of epitope recognition and enhanced sensitivity.

Mcl-1, a member of the Bcl-2 family of proteins, plays a crucial role in regulating apoptosis and cell survival. It is known to be overexpressed in various cancers, making it an attractive target for therapeutic interventions. The Mcl-1 Polyclonal Antibody offers researchers a reliable means to investigate the expression levels and localization of Mcl-1 in both normal and diseased tissues.

This antibody has been rigorously validated for its specificity and sensitivity through various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other Bcl-2 family members, ensuring accurate and reliable results.

The Mcl-1 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size and concentration, allowing for flexibility in experimental design. The antibody is compatible with a wide range of detection systems and can be used in both manual and automated protocols.

With its exceptional performance characteristics and broad applicability, the Mcl-1 Polyclonal Antibody is an indispensable tool for researchers studying apoptosis, cancer biology, and drug discovery. Its high specificity, sensitivity, and ease of use make it an ideal choice for both basic research and clinical applications.